← All Sponsors
SPONSOR

Vor Biopharma

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Primary Sjogren's Disease
NCT07404865 Phase 3
Recruiting

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

Primary Sjogren's Disease
United States View Trial →